Keywords
RepurposingCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineOutbreakDrug repositioningClinical trialCoronavirusCoronavirus InfectionsBetacoronavirusVirologyPneumoniaIntensive care medicinePharmacologyBiologyInfectious disease (medical specialty)Internal medicineDiseaseDrug
Affiliated Institutions
Related Publications
A Novel Coronavirus from Patients with Pneumonia in China, 2019
In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discov...
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycopr...
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
The recent emergence of Wuhan coronavirus (2019-nCoV) puts the world on alert. 2019-nCoV is reminiscent of the SARS-CoV outbreak in 2002 to 2003. Our decade-long structural stud...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 19
- Issue
- 3
- Pages
- 149-150
- Citations
- 1808
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1808
OpenAlex
Cite This
Guangdi Li,
Erik De Clercq
(2020).
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Nature Reviews Drug Discovery
, 19
(3)
, 149-150.
https://doi.org/10.1038/d41573-020-00016-0
Identifiers
- DOI
- 10.1038/d41573-020-00016-0